help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2009-0009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Kang, H.
Right arrow Articles by Ko, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, H.
Right arrow Articles by Ko, J.
Molecular Endocrinology 23 (11): 1746-1757
Copyright © 2009 by The Endocrine Society

A Novel Isoform of Human LZIP Negatively Regulates the Transactivation of the Glucocorticoid Receptor

Hyereen Kang1, Yoon Suk Kim1 and Jesang Ko

School of Life Sciences and Biotechnology (H.K., J.K.), Korea University, Seoul 136-701, South Korea; and Department of Biomedical Laboratory Science (Y.S.K.), College of Health Sciences, Yonsei University, Wonju 220-710, South Korea

Address all correspondence and requests for reprints to: Jesang Ko, School of Life Sciences and Biotechnology, Korea University, 5-1 Anam-dong, Seongbuk-gu, Seoul 136-701, Korea. E-mail: jesangko{at}korea.ac.kr.

The human leucine zipper protein (LZIP) is a basic leucine zipper transcription factor that is involved in leukocyte migration, tumor suppression, and endoplasmic reticulum stress-associated protein degradation. Although evidence suggests a diversity of roles for LZIP, its function is not fully understood, and the subcellular localization of LZIP is still controversial. We identified a novel isoform of LZIP and characterized its function in ligand-induced transactivation of the glucocorticoid receptor (GR) in COS-7 and HeLa cells. A novel isoform of human LZIP designated as "sLZIP" contains a deleted putative transmembrane domain (amino acids 229–245) of LZIP and consists of 345 amino acids. LZIP and sLZIP were ubiquitously expressed in a variety of cell lines and tissues, with LZIP being much more common. sLZIP was mainly localized in the nucleus, whereas LZIP was located in the cytoplasm. Unlike LZIP, sLZIP was not involved in the chemokine-mediated signal pathway. sLZIP recruited histone deacetylases (HDACs) to the promoter region of the mouse mammary tumor virus luciferase reporter gene and enhanced the activities of HDACs, resulting in suppression of expression of the GR target genes. Our findings suggest that sLZIP functions as a negative regulator in glucocorticoid-induced transcriptional activation of GR by recruitment and activation of HDACs.

NURSA Molecule Pages Link:

Nuclear Receptors:   GR
Coregulators:   HDAC4  |  HDAC1  |  HDAC2  |  HDAC3
Ligands:   Dexamethasone






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society